Literature DB >> 19262012

NADPH oxidase-derived reactive oxygen species are essential for differentiation of a mouse macrophage cell line (RAW264.7) into osteoclasts.

Hideyuki Sasaki1, Hironori Yamamoto, Kumiko Tominaga, Kiyoshi Masuda, Tomoko Kawai, Shigetada Teshima-Kondo, Kazuhito Rokutan.   

Abstract

Reactive oxygen species (ROS) derived from NADPH oxidase (Nox) homologues have been suggested to regulate osteoclast differentiation. However, no bone abnormalities have been documented in Nox1 deficient, Nox2 deficient, or Nox3 mutant mice. During receptor activator of nuclear factor-kappaB ligand (RANKL)-stimulated differentiation of a mouse macrophage cell line (RAW264.7) into osteoclasts, mRNA levels of Nox enzymes (Nox1-4) and their adaptor proteins were monitored by real-time reverse transcriptase PCR. RAW264.7 cells constitutively expressed abundant Nox2 mRNA and small amounts of Nox1 and Nox3 transcripts. RANKL markedly attenuated Nox2 mRNA expression in association with reciprocal up-regulation of Nox1 and Nox3 transcripts. Introduction of small interference RNA targeting p67(phox) or p22(phox) into RAW264.7 cells effectively down-regulated ROS generation and significantly suppressed the RANKL-stimulated differentiation, which was assessed by appearance of tartrate resistant acid phosphatase (TRAP)-positive, multinucleated cells having an ability to form resorption pits on calcium phosphate thin film-coated disks, and by expression of osteoclast marker genes (TRAP, cathepsin K, Atp6i, ClC-7, and NFATc1). Our results suggest that RANKL may stimulate switching between Nox homologues during osteoclast differentiation, and Nox-derived ROS may be crucial for RANKL-induced osteoclast differentiation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19262012     DOI: 10.2152/jmi.56.33

Source DB:  PubMed          Journal:  J Med Invest        ISSN: 1343-1420


  42 in total

1.  Inhibition of NADPH oxidases prevents chronic ethanol-induced bone loss in female rats.

Authors:  Jin-Ran Chen; Oxana P Lazarenko; Kartik Shankar; Michael L Blackburn; Charles K Lumpkin; Thomas M Badger; Martin J J Ronis
Journal:  J Pharmacol Exp Ther       Date:  2010-11-22       Impact factor: 4.030

2.  Nox2 Activity Is Required in Obesity-Mediated Alteration of Bone Remodeling.

Authors:  Md Mizanur Rahman; Amina El Jamali; Ganesh V Halade; Allal Ouhtit; Haissam Abou-Saleh; Gianfranco Pintus
Journal:  Oxid Med Cell Longev       Date:  2018-11-08       Impact factor: 6.543

3.  Rosmarinic acid and arbutin suppress osteoclast differentiation by inhibiting superoxide and NFATc1 downregulation in RAW 264.7 cells.

Authors:  Akina Omori; Yoshitaka Yoshimura; Yoshiaki Deyama; Kuniaki Suzuki
Journal:  Biomed Rep       Date:  2015-04-17

4.  NADPH oxidase 4 represents a potential target for the treatment of osteoporosis.

Authors:  Paula Hoff; Frank Buttgereit
Journal:  Cell Mol Immunol       Date:  2014-03-03       Impact factor: 11.530

5.  Sphingolipids and Redox Signaling in Renal Regulation and Chronic Kidney Diseases.

Authors:  Owais M Bhat; Xinxu Yuan; Guangbi Li; RaMi Lee; Pin-Lan Li
Journal:  Antioxid Redox Signal       Date:  2018-01-09       Impact factor: 8.401

Review 6.  Cooperative electrogenic proton transport pathways in the plasma membrane of the proton-secreting osteoclast.

Authors:  Miyuki Kuno
Journal:  Pflugers Arch       Date:  2018-03-17       Impact factor: 3.657

7.  Macrophage-specific up-regulation of apolipoprotein E gene expression by STAT1 is achieved via long range genomic interactions.

Authors:  Violeta Georgeta Trusca; Elena Valeria Fuior; Irina Cristina Florea; Dimitris Kardassis; Maya Simionescu; Anca Violeta Gafencu
Journal:  J Biol Chem       Date:  2011-03-03       Impact factor: 5.157

8.  NADPH oxidase 4 limits bone mass by promoting osteoclastogenesis.

Authors:  Claudia Goettsch; Andrea Babelova; Olivia Trummer; Reinhold G Erben; Martina Rauner; Stefan Rammelt; Norbert Weissmann; Valeska Weinberger; Sebastian Benkhoff; Marian Kampschulte; Barbara Obermayer-Pietsch; Lorenz C Hofbauer; Ralf P Brandes; Katrin Schröder
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

9.  Treatment with hydrogen molecules prevents RANKL-induced osteoclast differentiation associated with inhibition of ROS formation and inactivation of MAPK, AKT and NF-kappa B pathways in murine RAW264.7 cells.

Authors:  Dong-Zhu Li; Qing-Xiang Zhang; Xiao-Xian Dong; Huai-Dong Li; Xin Ma
Journal:  J Bone Miner Metab       Date:  2013-11-07       Impact factor: 2.626

Review 10.  NADPH oxidases in bone homeostasis and osteoporosis.

Authors:  Katrin Schröder
Journal:  Cell Mol Life Sci       Date:  2014-08-29       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.